With IDEA Pharma’s US operations securing an ever-stronger foothold, awareness is growing as the company sees its reach widen into new areas of opportunity from New York to New Jersey, through to Philadelphia and Tennessee, not to mention moving further north into Canada.

Following such early adopters, more Pharma companies are realising the importance of getting strategy right at Phase II; IDEA is delighted to announce the recent appointment of Amy Wasserman as Director, Client Value – IDEA Pharma’s oracle on all things New York.

With a firm background in Pharma sales and marketing, Amy joins IDEA from Astellas US. Commenting on her recent appointment, Amy said:

“I really believe that IDEA has a unique standing within the pharmaceutical industry, and the work it conducts has proven to be revolutionary for all of the brands and teams it supports. I am driven by facing challenges head on, and firmly believe the work that IDEA does has the impact to transform Pharma into a space where innovation is cultivated and rewarded… The signs of adoption are already great within the US market, and I relish the opportunity to generate new business throughout the country.”

“Our business is only about people – great people. Finding such a diverse, yet honed talent in one individual offers up such an exciting opportunity for our business to continue to make strong headway across the length and breadth of the US. Her track record speaks for itself, and her enthusiasm and tenacity fits nicely into our outstanding team dynamic. Our work often relies heavily on building instant relationships, as well as knowing your stuff… and Amy certainly delivers on both counts. I am delighted to welcome her to the IDEA family,” comments Mike Rea, IDEA’s CEO.

Amy’s passion for being in the know does not stop at Pharma… she is also the go-to person for all things New York, giving advice on what’s hot and what is not in the city and beyond.